Frankie Maldonado, the Director of Operations for Life Guard Imaging joins Gayle Guyardo, the host of Bloom, to share more ...

Patients with CRC who test positive for ctDNA following curative resection show poorer disease-free survival but a greater ...

Before you leave... As a nonprofit newsroom, we believe the healthiest way to sustain and grow CT Mirror is through the support of people who use and value it — loyal, curious readers like you.

The opinions expressed by contributors are theirs alone. CT Mirror welcomes rebuttal or opposing views to this and all its commentaries. Read our guidelines and submit your commentary here.

Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease ...

This review explores the role of PET in imaging immune activation, particularly in oncology. 18F-FDG is widely used for assessing treatment response to immunotherapies and can demonstrate unique ...

The following is a summary of "What is the accuracy, sensitivity and specificity of the radiological peritoneal cancer index ...

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).

Methods: Between February 1995 and February 2001, 24 patients who underwent surgical resection for dilations of the bile duct (peripheral and hilar) without visible mass lesion on US or CT were ...

Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure. The European Commission revoked the conditional ...

Yu J et al. Deep Learning–based Quantitative CT Myocardial Perfusion Imaging and Risk Stratification of Coronary Artery Disease. Radiology. 2025;DOI: 10.1148/radiol.242570.